BioSpace News Archive

They dub it a type of Trojan Horse and believe it has the potential to treat atherosclerosis, a top cause of death in the U.S.

All three companies have invested millions in the facilities to expand their global footprint.

Krystal Biotech and Foghorn Therapeutics are beginning 2020 with significant expansion projects.

Pharma companies from across the globe provide updates on their pipelines and business.

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2019 financial results on Thursday, February 6, 2020, after the market close.

Today, the U.S. Food and Drug Administration announced the launch of an interactive database that will offer a wealth of critical information about antiretrovirals (ARVs) eligible for purchase under the President’s Emergency Plan for AIDS Relief (PEPFAR) program.

American Healthcare Investors, the co-sponsor of Griffin-American Healthcare REIT III, Inc. and Griffin-American Healthcare REIT IV, Inc., announced today that the company completed the acquisition of four medical office buildings, one integrated senior health campus and one land parcel for an aggregate contract purchase price of approximately $44 million,

Align Technology, Inc. (Nasdaq: ALGN) today reported financial results for the fourth quarter (Q4’19) and year ended December 31, 2019 (2019). Q4’19 total revenues were $649.8 million, up 21.7% year-over-year

Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that it intends to offer its securities in an underwritten public offering.

CONMED Corporation (NASDAQ: CNMD) today announced that it is transferring the listing of its common stock to the New York Stock Exchange (NYSE) from the NASDAQ Global Market.